The Global Virus Network (GVN), representing eminent human and animal virologists from more than 90 Centers of Excellence and Affiliates in over 40 countries dedicated to advancing research, collaboration, and pandemic preparedness, is monitoring the SARS-CoV-2 variant BA.3.2, sometimes informally referred to in media reports as the "cicada" variant, and emphasizes that current evidence does not indicate cause for alarm or heightened public concern.

3 Apr 2026

Study finds gaps in preventive care for women with diabetes

Physicians are less likely to provide preventive care such as conception counseling and some cancer screenings to women with diabetes than they do for women without the disease, a UCLA-led study suggests.

3 Apr 2026

Kazakhstan study identifies factors driving job satisfaction and retention intentions among nurses

A new study examines what drives job satisfaction and retention intentions among nurses working in public clinical centers in Kazakhstan.

3 Apr 2026

Study shows how environmental factors accelerate biological age of the brain

The latest findings from the Global Brain Health Institute (GBHI) at Trinity College Dublin identify important brain health implications for prevention, public health, and policy.

3 Apr 2026

University Hospitals earns top honor at the 2026 Connected Healthcare Summit

University Hospitals has been recognized by RLDatix with the Innovation in Regulatory & Compliance Award at the 2026 Connected Healthcare Summit.

3 Apr 2026

Giving families interpreter access doubles communication time in PICU

Language barriers may be particularly harmful in the pediatric intensive care unit (PICU), where families encounter challenging, often life-changing medical decisions. In many hospitals, a member of the healthcare team, and not the family, decides when to use interpretation services.

3 Apr 2026

Pediatric experts say plain yogurt is safe from 6 months and belongs in a baby’s diet

An expert panel review says plain, whole yogurt with no added sugar or sweeteners can be introduced from 6 months as part of complementary feeding, provided it does not replace breast milk or infant formula as the main source of nutrition. It also explains that yogurt provides live microorganisms and key nutrients, is generally well tolerated, and helps address common myths about inflammation, mucus, acne, sugar, and safety.

2 Apr 2026

Smartphone app HabitWorks improves anxiety and depression symptoms

In an effort to increase access to evidence-based interventions to help manage anxiety and depression, Mass General Brigham investigators have developed and tested a novel digital intervention called HabitWorks.

2 Apr 2026

High-dose flu shots inked to lower Alzheimer's dementia risk in older adults

A large US claims-based study found that adults aged 65 and older who received a high-dose flu vaccine had a lower observed risk of Alzheimer dementia than those who received a standard-dose vaccine, with the association lasting up to 25 months in per-protocol analyses and 28 months in intention-to-treat analyses. The signal appeared stronger and more sustained in women, though the authors stress that the findings are observational and need confirmation in longer prospective studies.

2 Apr 2026

Oral molecule prevents kidney stones and restores survival in mice

Scientists at the Buck Institute for Research on Aging have shown that an orally administered small molecule, N-propargylglycine (N-PPG), can completely prevent the formation of calcium oxalate kidney stones, protect against kidney failure, and fully restore normal survival in a mouse model of Primary Hyperoxaluria Type 2 (PH2), a rare and currently untreatable genetic disorder that causes progressive kidney failure in infants and young adults.

2 Apr 2026

Sleep apnea raises risk of cardiovascular events and death

New research to be presented at this year's European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12-15 May) shows that those living with obstructive sleep apnea (OSA) have a 71% higher risk of cardiovascular events (CVEs) or death from any cause (all-cause mortality) compared with those not living with OSA.

2 Apr 2026

Northumbria University spinout earns CE mark for breath sampling device

A medical device company spun out of Northumbria University has reached a significant milestone — receiving CE marking for a breath sampling platform that peer-reviewed research has demonstrated can reliably collect saliva-free exhaled breath condensates (EBC) from the deep lung, making it the first technology of its type to achieve this distinction.

2 Apr 2026

New drying technique stabilizes vital vaccines at room temperature

A significant challenge in global healthcare and biotechnology is the "cold chain"-the network of refrigerated storage and transport required to keep protein-based drugs, vaccines, and diagnostic tests from degrading.

2 Apr 2026

Flu vaccine halves heart attack risk after breakthrough infection

Influenza vaccination could significantly reduce the risk of influenza-associated heart attack and stroke even among people who get infected after getting the vaccine, according to research just published in Eurosurveillance.

2 Apr 2026

Study explores how a powerful antiseptic affects bacteria in hospital environments

Just because a topical antiseptic is swabbed on the skin doesn't mean it stays on the skin.

2 Apr 2026

Finnish study reveals how parental immigration status impacts child mental health

A new nationwide Finnish register study shows that children with two immigrant parents are significantly less likely to receive mental health services for anxiety and depression than children of Finnish parents.

2 Apr 2026

Wegovy® (semaglutide injection) 2.4 mg recommended by NICE to reduce risk of major adverse cardiovascular events, including heart attacks and strokes, in adults with established cardiovascular disease and overweight or obesity (BMI ≥ 27 kg/m2)

NICE has recommended Wegovy® (semaglutide injection) 2.4 mg as the first GLP-1 RA to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established cardiovascular disease and either obesity or overweight (BMI ≥ 27 kg/m2).

From Novo Nordisk 2 Apr 2026

NCCN conference highlights advances in global cancer care strategies

The National Comprehensive Cancer Network® (NCCN®)-a non-profit alliance of leading cancer centers-brought together more than a thousand oncology professionals at the NCCN 2026 Annual Conference in Orlando, Florida, with hundreds more joining virtually.

1 Apr 2026

Extreme heat linked to higher risk of low birth weight babies

Exposure to extreme heat conditions is resulting in more babies being born with low birth weight, according to a new study involving Adelaide University researchers.

1 Apr 2026

AI scribes modestly reduce clinician documentation time and EHR use

Documenting a patient visit in the electronic health record (EHR) is essential to healthcare delivery, but also a major contributor to clinician burnout.

1 Apr 2026